NAS:YTEN (USA) Also trade in: Germany

Yield10 Bioscience Inc

$ 0.95 0.04 (4.4%)
Volume: 6,066 Avg Vol (1m): 147,216
Market Cap $: 11.87 Mil Enterprise Value $: 5.81 Mil
P/E (TTM): 0.00 P/B: 1.61
Earnings Power Value -18.77
Net Current Asset Value -0.02
Tangible Book 0.15
Projected FCF -14.66
Median P/S Value 1.07
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 6.6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt range over the past 10 years
Min: 2.82, Med: 10000, Max: 10000
Current: 10000
2.82
10000
Equity-to-Asset 0.47
Equity-to-Asset range over the past 10 years
Min: -6.36, Med: 0.68, Max: 0.95
Current: 0.47
-6.36
0.95
Interest Coverage No Debt
N/A
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -38.63
DISTRESS
GREY
SAFE
Beneish M-Score 2.03
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -3069.67%
WACC 10.88%

Profitability & Growth : 2/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -1492.26
Operating Margin range over the past 10 years
Min: -8691.74, Med: -970.78, Max: 9.49
Current: -1492.26
-8691.74
9.49
Net Margin % -1474.19
Net Margin range over the past 10 years
Min: -8661.38, Med: -1352.04, Max: 8.77
Current: -1474.19
-8661.38
8.77
ROE % -112.97
ROE range over the past 10 years
Min: -150.71, Med: -97.02, Max: 8.36
Current: -112.97
-150.71
8.36
ROA % -79.51
ROA range over the past 10 years
Min: -118.44, Med: -61.32, Max: 5.32
Current: -79.51
-118.44
5.32
ROC (Joel Greenblatt) % -646.27
ROC (Joel Greenblatt) range over the past 10 years
Min: -4445.28, Med: -1174.91, Max: 216.24
Current: -646.27
-4445.28
216.24
3-Year Total Revenue Growth Rate -25.60
3-Year Revenue Growth Rate range over the past 10 years
Min: -80.5, Med: -46.25, Max: 170.9
Current: -53
-80.5
170.9
3-Year Total EBITDA Growth Rate 9.40
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 10.7, Max: 58.2
Current: 42.8
0
58.2
3-Year EPS w/o NRI Growth Rate 43.10
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 11.35, Max: 59.5
Current: 43.1
0
59.5

» YTEN's 30-Y Financials

Financials (Next Earnings Date: 2019-08-10 Est.)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:YTEN

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Chemicals » Chemicals    NAICS : 325998    SIC : 5169
Compare TSE:4616 OSTO:POLYG BOM:507580 BKK:DIMET-R ASX:CFO TSE:4361 ASX:DTZ XKLS:7223 OSTO:AERO XKLS:8052 BOM:526159 BOM:526739 HKSE:08151 XKLS:0054 BOM:500159 BOM:539939 BOM:541778 BOM:531253 OTCPK:ADMT NAS:IKNX
Traded in other countries M6X2.Germany
Address 19 Presidential Way, Woburn, MA, USA, 01801
Yield10 Bioscience Inc is an agricultural bioscience company. It focuses on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. The company uses two proprietary advanced biotechnology trait gene discovery platforms to improve fundamental crop yield through enhanced photosynthetic carbon capture and increased carbon utilization efficiency to increase seed yield. Having developed various crops, such as Camelina, canola, soybean, and corn, the firm concentrates to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter.

Ratios

Current vs industry vs history
PB Ratio 1.61
PB Ratio range over the past 10 years
Min: 0.69, Med: 2.97, Max: 18.67
Current: 1.61
0.69
18.67
PS Ratio 15.33
PS Ratio range over the past 10 years
Min: 0.94, Med: 17.23, Max: 725.84
Current: 15.33
0.94
725.84
EV-to-EBIT -0.63
EV-to-EBIT range over the past 10 years
Min: -114.7, Med: -1.1, Max: 18.5
Current: -0.63
-114.7
18.5
EV-to-EBITDA -0.65
EV-to-EBITDA range over the past 10 years
Min: -10.7, Med: -1.1, Max: 38.6
Current: -0.65
-10.7
38.6
EV-to-Revenue 9.39
EV-to-Revenue range over the past 10 years
Min: -7.9, Med: 11.7, Max: 609.8
Current: 9.39
-7.9
609.8
Current Ratio 4.49
Current Ratio range over the past 10 years
Min: 1.4, Med: 8.18, Max: 38.31
Current: 4.49
1.4
38.31
Quick Ratio 4.49
Quick Ratio range over the past 10 years
Min: 1.3, Med: 7.65, Max: 38.31
Current: 4.49
1.3
38.31
Days Sales Outstanding 26.49
Days Sales Outstanding range over the past 10 years
Min: 4.87, Med: 29.14, Max: 681.12
Current: 26.49
4.87
681.12

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -53.80
3-Year Share Buyback Rate range over the past 10 years
Min: -102.4, Med: -55, Max: -5.8
Current: -53.8
-102.4
-5.8

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 6.33
Price-to-Tangible-Book range over the past 10 years
Min: 1.01, Med: 3.35, Max: 18.35
Current: 6.33
1.01
18.35
Price-to-Median-PS-Value 0.89
Price-to-Median-PS-Value range over the past 10 years
Min: 0.07, Med: 1.12, Max: 42.09
Current: 0.89
0.07
42.09
Earnings Yield (Joel Greenblatt) % -159.17
Earnings Yield (Greenblatt) range over the past 10 years
Min: -4971.3, Med: -58.8, Max: 3016.1
Current: -159.17
-4971.3
3016.1

More Statistics

Revenue (TTM) (Mil) $ 0.62
EPS (TTM) $ -0.91
Beta 1.46
Volatility % 72
52-Week Range $ 0.68 - 1.77
Shares Outstanding (Mil) 12.49

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 3
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N